Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. | 209,290 | reported | 29 May 2026 | tx 11+584,550−15,155 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2026 | EXERCISE | Monte Rosa Therapeutics, Inc. | 6,000 | 6.14 USD | 10b5-1 |
| 29 May 2026 | SALE | Monte Rosa Therapeutics, Inc. | 6,000 | 19.87 USD | 10b5-1 |
| 29 May 2026 | EXERCISE | Monte Rosa Therapeutics, Inc. | 6,000 | 0.00 USD | 10b5-1deriv |
| 02 Jan 2026 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 35,000 | — | |
| 05 Jan 2026 | SALE | Monte Rosa Therapeutics, Inc. | 3,155 | 15.17 USD | |
| 02 Jan 2026 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 158,000 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 36,000 | — | |
| 02 Jan 2025 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 161,000 | 0.00 USD | deriv |
| 03 Jun 2024 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 03 Jan 2023 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 78,550 | 0.00 USD | deriv |
| 01 Mar 2022 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 70,000 | 0.00 USD | deriv |